Scam Alert
The Kentucky Board of Pharmacy has been made aware that some licensees have received fraudulent communications from individuals claiming to be from the Board of Pharmacy, or another agency, such as the DEA. The communications, often by phone, and even by letter may threaten arrest or license suspension, demand personal information, or require the payment of fines. Please note:
- Phone calls may “spoof” appear to be from our number;
- If you need to verify the identity of a KY Board of Pharmacy investigator, call
502-564-7910 or email
pharmacy.board@ky.gov
- The Kentucky Board of Pharmacy will never demand that you provide personally identifying information, such as social security number, date of birth, bank or credit card account numbers over the phone;
- These type of licensing scams are a problem nationwide.
If you believe you are the recipient of a fraudulent communication claiming to be from the Kentucky Board of Pharmacy:
The Drug Enforcement Administration also has warned of imposters posing as DEA agents. Information and reporting of these scams can be found at this DEA website.
Recently Filed Amendments to Regulations and New Regulations
201 KAR 2:210, Patient records, drug regimen review, patient counseling, and final product verification . Amendment. This amendment re-orders the sections of the regulation and adds sections and definitions regarding the regulation of automated filling systems and final product verification. An agency amendment will authorize final product verification outside of the pharmacy with Board approval. This regulation is pending the ARRS Committee meeting on December 9, 2024.
201 KAR 2:480, Telework and Electronic Supervision for Remote Prescription Processing. New Regulation. KRS 315.020(5) authorizes order entry, order entry verification and drug regimen review as tasks that can be performed outside of the permitted space of the pharmacy. The purpose of this administrative regulation is to provide minimum requirements for pharmacies located in Kentucky engaged in remote prescription processing conducted via telework and to establish rules for electronic supervision. This regulation is pending the interim joint health services committee in December.
201 KAR 2:370, Pharmacy Services in long-term care facility. Amendment filed June 4, 2024: This amendment defines “tamper-resistant secure container" and amends the definition for “long-term care facility." This amendment is pending the interim joint health services committee in December.
201 KAR 2:050 , Licenses and permits; fees. Amendment filed April 15, 2024: This amendment clarifies that all fees are non-refundable and that applications shall expire after one year of receipt. An agency amendment has been filed to remove any provision regarding non-resident licensure of pharmacists. This regulation is pending the ARRS Committee meeting on December 9, 2024.
201 KAR 2:030 , License transfer and non-resident pharmacist license. Amendment filed April 15, 2024: This amendment defines “good standing." An agency amendment has been filed to remove any provision regarding non-resident licensure of pharmacists. This regulation is pending the ARRS Committee meeting on December 9, 2024.
201 KAR 2:465 , Non-Resident Pharmacy Applications and Waivers. New Administrative Regulation filed April 15, 2024: This regulation details the application process for non-resident pharmacies and clarifies language in KRS 315.0351, including the waiver for “isolated transactions" language. An agency amendment has been filed to remove any provision regarding non-resident licensure of pharmacists. This regulation is pending the ARRS Committee meeting on December 9, 2024.